These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 10074499)

  • 1. Clinical significance of expression of human cytomegalovirus pp67 late transcript in heart, lung, and bone marrow transplant recipients as determined by nucleic acid sequence-based amplification.
    Gerna G; Baldanti F; Middeldorp JM; Furione M; Zavattoni M; Lilleri D; Revello MG
    J Clin Microbiol; 1999 Apr; 37(4):902-11. PubMed ID: 10074499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human cytomegalovirus immediate-early mRNA detection by nucleic acid sequence-based amplification as a new parameter for preemptive therapy in bone marrow transplant recipients.
    Gerna G; Baldanti F; Lilleri D; Parea M; Alessandrino E; Pagani A; Locatelli F; Middeldorp J; Revello MG
    J Clin Microbiol; 2000 May; 38(5):1845-53. PubMed ID: 10790111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of CMV transcripts for monitoring of CMV infections in transplant recipients.
    Gerna G; Baldanti F; Middeldorp J; Lilleri D
    Int J Antimicrob Agents; 2000 Dec; 16(4):455-60. PubMed ID: 11118857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic value of monitoring human cytomegalovirus late pp67 mRNA expression in renal-allograft recipients by nucleic acid sequence-based amplification.
    Blok MJ; Goossens VJ; Vanherle SJ; Top B; Tacken N; Middeldorp JM; Christiaans MH; van Hooff JP; Bruggeman CA
    J Clin Microbiol; 1998 May; 36(5):1341-6. PubMed ID: 9574702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of late pp67-mRNA by NASBA in peripheral blood for the diagnosis of human cytomegalovirus disease in AIDS patients.
    Blank BS; Meenhorst PL; Pauw W; Mulder JW; van Dijk WC; Smits PH; Roeles F; Middeldorp JM; Lange JM
    J Clin Virol; 2002 Jul; 25(1):29-38. PubMed ID: 12126719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinically-based determination of safe DNAemia cutoff levels for preemptive therapy or human cytomegalovirus infections in solid organ and hematopoietic stem cell transplant recipients.
    Lilleri D; Baldanti F; Gatti M; Rovida F; Dossena L; De Grazia S; Torsellini M; Gerna G
    J Med Virol; 2004 Jul; 73(3):412-8. PubMed ID: 15170637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct quantification of human cytomegalovirus immediate-early and late mRNA levels in blood of lung transplant recipients by competitive nucleic acid sequence-based amplification.
    Greijer AE; Verschuuren EA; Harmsen MC; Dekkers CA; Adriaanse HM; The TH; Middeldorp JM
    J Clin Microbiol; 2001 Jan; 39(1):251-9. PubMed ID: 11136779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of CMV load in solid organ transplant recipients by pp65 antigenemia and real-time quantitative DNA PCR assay: correlation with pp67 RNA detection.
    Mengoli C; Cusinato R; Biasolo MA; Cesaro S; Parolin C; Palù G
    J Med Virol; 2004 Sep; 74(1):78-84. PubMed ID: 15258972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic implications of human cytomegalovirus immediate early-1 and pp67 mRNA detection in whole-blood samples from liver transplant patients using nucleic acid sequence-based amplification.
    Blok MJ; Lautenschlager I; Goossens VJ; Middeldorp JM; Vink C; Höckerstedt K; Bruggeman CA
    J Clin Microbiol; 2000 Dec; 38(12):4485-91. PubMed ID: 11101584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary report for the application of nucleic acid sequence-based amplification in detection of human cytomegalovirus (HCMV) late pp67 mRNA for diagnosis of HCMV infection.
    Pairoj W; Srichunrusami C; Chantratita W; Bodhiphala P; Sungkanuparph S; Vibhagool A
    J Med Assoc Thai; 2000 Mar; 83 Suppl 1():S28-34. PubMed ID: 10865403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective study comparing cytomegalovirus antigenemia, DNAemia and RNAemia tests in guiding pre-emptive therapy in thoracic organ transplant recipients.
    Lehto JT; Lemström K; Halme M; Lappalainen M; Lommi J; Sipponen J; Harjula A; Tukiainen P; Koskinen PK
    Transpl Int; 2005 Dec; 18(12):1318-27. PubMed ID: 16297050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic value of nucleic-acid-sequence- based amplification for the detection of cytomegalovirus infection in renal and liver transplant recipients.
    Goossens VJ; Blok MJ; Christiaans MH; van Hooff JP; Sillekens P; Höckerstedt K; Lautenschlager I; Middeldorp JM; Bruggeman CA
    Intervirology; 1999; 42(5-6):373-81. PubMed ID: 10702720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of human cytomegalovirus (HCMV) pp67-mRNA and pp65 antigenemia in relation to development of clinical HCMV disease in renal transplant recipients.
    Degré M; Kristiansen KI; Rollag H; Holter E; Nordal KP
    Clin Microbiol Infect; 2001 May; 7(5):254-60. PubMed ID: 11422252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human cytomegalovirus (HCMV) leukodnaemia correlates more closely with clinical symptoms than antigenemia and viremia in heart and heart-lung transplant recipients with primary HCMV infection.
    Gerna G; Zavattoni M; Baldanti F; Sarasini A; Chezzi L; Grossi P; Revello MG
    Transplantation; 1998 May; 65(10):1378-85. PubMed ID: 9625022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic significance and clinical impact of quantitative assays for diagnosis of human cytomegalovirus infection/disease in immunocompromised patients.
    Gerna G; Percivalle E; Baldanti F; Sarasini A; Zavattoni M; Furione M; Torsellini M; Revello MG
    New Microbiol; 1998 Jul; 21(3):293-308. PubMed ID: 9699213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the NucliSens CMV pp67 assay for detection and monitoring of human cytomegalovirus infection after allogeneic stem cell transplantation.
    Hebart H; Rudolph T; Loeffler J; Middeldorp J; Ljubicic T; Jahn G; Einsele H
    Bone Marrow Transplant; 2002 Aug; 30(3):181-7. PubMed ID: 12189537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human cytomegalovirus pp67 mRNAemia versus pp65 antigenemia for guiding preemptive therapy in heart and lung transplant recipients: a prospective, randomized, controlled, open-label trial.
    Gerna G; Baldanti F; Lilleri D; Parea M; Torsellini M; Castiglioni B; Vitulo P; Pellegrini C; Viganò M; Grossi P; Revello MG
    Transplantation; 2003 Apr; 75(7):1012-9. PubMed ID: 12698090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression dynamics of human cytomegalovirus immune evasion genes US3, US6, and US11 in the blood of lung transplant recipients.
    Greijer AE; Verschuuren EA; Dekkers CA; Adriaanse HM; van der Bij W; The TH; Middeldorp JM
    J Infect Dis; 2001 Aug; 184(3):247-55. PubMed ID: 11443549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective evaluation of the clinical utility of different methods for the detection of human cytomegalovirus disease after liver transplantation.
    Seehofer D; Meisel H; Rayes N; Stein A; Langrehr JM; Settmacher U; Neuhaus P
    Am J Transplant; 2004 Aug; 4(8):1331-7. PubMed ID: 15268736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analytical performance and clinical utility of a nucleic acid sequence-based amplification assay for detection of cytomegalovirus infection.
    Witt DJ; Kemper M; Stead A; Sillekens P; Ginocchio CC; Espy MJ; Paya CV; Smith TF; Roeles F; Caliendo AM
    J Clin Microbiol; 2000 Nov; 38(11):3994-9. PubMed ID: 11060058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.